ADVERSE DRUG REACTION (ADR) MONITORING AND PHARMACOVIGILANCE

被引:0
|
作者
Kavitha, D. [1 ]
机构
[1] Andhra Univ, Univ Coll Pharmaceut Sci, Div Pharmacol, Visakhapatnam, Andhra Pradesh, India
关键词
Adverse drug reaction; Pharmacovigilance; Post marketing surveillance;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The need for systematic follow up of medicines for adverse drug reactions once they are introduced into general use has been widely recognised today. Even in developing countries like India, national pharmacovigilance programme has been started for monitoring adverse drug reactions. In its first year this program mainly aimed to foster the culture of ADR notification among health care professionals. As a part of health care team every pharmacist must have knowledge about adverse drug reaction monitoring systems and pharmacovigilance.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 50 条
  • [11] Adverse Drug Reaction Monitoring in Elderly on Psychotropic Drugs in the Department of Psychiatry: A Pharmacovigilance Report
    Srivatsa, Shweta
    Jayanthi, C. R.
    Chandrashekar, H.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S88 - S88
  • [12] Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil
    Alves de Araujo Lobo, Marcia Germana
    Botelho Pinheiro, Sandra Maria
    Diaz Castro, Jose Gerley
    Momente, Valeria Gomes
    Pranchevicius, Maria-Cristina S.
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14
  • [13] Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory Landscape
    Lengsavath, Marina
    Dal Pra, Anne
    de Ferran, Anne-Marie
    Brosch, Sabine
    Harmark, Linda
    Newbould, Victoria
    Goncalves, Susana
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (01) : 125 - 131
  • [14] Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory Landscape
    Marina Lengsavath
    Anne Dal Pra
    Anne-Marie de Ferran
    Sabine Brosch
    Linda Härmark
    Victoria Newbould
    Susana Goncalves
    [J]. Therapeutic Innovation & Regulatory Science, 2017, 51 : 125 - 131
  • [15] Knowledge, attitude, and practices (KAP) of the Pharm.D interns towards adverse drug reaction (ADR) reporting and pharmacovigilance
    Venkatasubbaiah, Meda
    Reddy, P. Dwarakanadha
    Satyanarayana, Suggala, V
    [J]. PHARMACY EDUCATION, 2021, 21 (01): : 186 - 193
  • [16] Adverse Drug Reaction (ADR) Monitoring in Patient Receiving Oncologic Medications: A 3 Months Study
    Kaur, Kanwalpreet
    Biswas, Pipasha N.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S164 - S165
  • [17] Adverse drug reaction reporting in a pharmacovigilance centre of Nepal
    Jha, N.
    Shankar, P. R.
    Bajracharya, O.
    Gurung, S. B.
    Singh, K. K.
    [J]. AUSTRALASIAN MEDICAL JOURNAL, 2012, 5 (05): : 268 - 271
  • [18] Underreporting Adverse Drug Reactions (ADR) and Medication Errors (ME): a Problem in Hospital Pharmacovigilance
    Garza-Ocanas, L.
    Escobedo Pena, J.
    Gonzalez-Nieto, C.
    Perez-Rodriguez, E.
    Guzman-Lopez, S.
    Aponte, E.
    Riojas-Hernandez, P.
    [J]. DRUG SAFETY, 2015, 38 (10) : 985 - 985
  • [19] Pharmacovigilance: Quality and assessment of published suspected adverse drug reactions (ADR) of herbal medicines
    Wegener, T
    [J]. DRUG SAFETY, 2006, 29 (04) : 370 - 370
  • [20] Adverse drug reaction monitoring
    Bhosale, Vivek V.
    Gaur, S. P. S.
    [J]. CURRENT SCIENCE, 2011, 101 (08): : 1024 - 1027